all

It is a pleasure and an honor to serve as the new president of the New England chapter of the National Lipid Association.  I hope I can live up to the accomplishments of my predecessor, Joyce Ross!  My goal is to serve the NLA members in the northeast by highlighting our CME activities, promoting the cause of/need for lipid expertise and forming a bridge to national involvement.

The 2014 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw another increase — from 3.587 (2013) to 3.904 (2014). The Journal is now ranked 44th out of 254 journals in its category (pharmacology and pharmacy). The Thomson-Reuters Impact Factor represents the ratio of articles quoted in other scientific publications compared to the total qualifying articles during the years 2012 and 2013. 

Abstract: The Roundtable in this issue of the journal has to do with a very important topic that has generated much debate and confusion over the years. Do women and men need and receive the same type and intensity of drug therapy to appropriately reduce the incidence of major vascular events? Second, do women respond to lipid-lowering medications with similar changes in lipoprotein levels and with equivalent reduction in major cardiovascular clinical events? ....